OpenArc Corporate Advisory’s Sanofi SNY Stock Holding History

OpenArc Corporate Advisory’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$435K	Buy	10,192 +4,600	+82%	+$206K	0.01%	523
2026 Q1	$269K	Buy	+5,592	New	+$261K	﹤0.01%	597

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

OpenArc Corporate Advisory's SNY Position: Q2 2026 in Review

OpenArc Corporate Advisory increased its Sanofi (SNY) stake by 82% in Q2 2026, buying an estimated $206K and bringing the position to 10,192 shares worth $435K. The position accounts for 0.01% of the portfolio, ranked #523.

OpenArc Corporate Advisory first reported a position in SNY in Q1 2026 and has held it in 2 quarters since. 714 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

OpenArc Corporate Advisory held 10,192 shares of Sanofi worth $435K as of Q2 2026.
OpenArc Corporate Advisory bought 4,600 Sanofi shares in Q2 2026, an estimated $206K.
Sanofi made up 0.01% of OpenArc Corporate Advisory's portfolio in Q2 2026, its #523 holding.
OpenArc Corporate Advisory first reported a position in Sanofi in Q1 2026 and has held it in 2 quarters since.
714 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on OpenArc Corporate Advisory's 13F filing for Q2 2026, filed 5 Aug 2026.